| Apolipoprotein B mRNA editing in 12 different mammalian species: hepatic expression is reflected in low concentrations of apoB-containing plasma lipoproteins J Greeve, I Altkemper, JH Dieterich, H Greten, E Windler Journal of lipid research 34 (8), 1367-1383, 1993 | 363 | 1993 |
| Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104: H4 induced haemolytic uraemic syndrome: case-control study J Menne, M Nitschke, R Stingele, M Abu-Tair, J Beneke, J Bramstedt, ... Bmj 345, 2012 | 341 | 2012 |
| Interferon‐inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication M Bonvin, F Achermann, I Greeve, D Stroka, A Keogh, D Inderbitzin, ... Hepatology 43 (6), 1364-1374, 2006 | 313 | 2006 |
| Involvement of KSRP in the post-transcriptional regulation of human iNOS expression–complex interplay of KSRP with TTP and HuR K Linker, A Pautz, M Fechir, T Hubrich, J Greeve, H Kleinert Nucleic acids research 33 (15), 4813-4827, 2005 | 242 | 2005 |
| Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas J Greeve, A Philipsen, K Krause, W Klapper, K Heidorn, BE Castle, ... Blood, The Journal of the American Society of Hematology 101 (9), 3574-3580, 2003 | 226 | 2003 |
| Purification and molecular cloning of a novel essential component of the apolipoprotein B mRNA editing enzyme-complex H Lellek, R Kirsten, I Diehl, F Apostel, F Buck, J Greeve Journal of Biological Chemistry 275 (26), 19848-19856, 2000 | 206 | 2000 |
| FOLFOXIRI Plus Panitumumab As First-Line Treatment of RAS Wild-Type Metastatic Colorectal Cancer: The Randomized, Open-Label, Phase II VOLFI Study (AIO … DP Modest, UM Martens, J Riera-Knorrenschild, J Greeve, A Florschütz, ... Journal of Clinical Oncology 37 (35), 3401-3411, 2019 | 181 | 2019 |
| Sequence requirements for the editing of apolipoprotein B mRNA. RR Shah, TJ Knott, JE Legros, N Navaratnam, JC Greeve, J Scott Journal of Biological Chemistry 266 (25), 16301-16304, 1991 | 181 | 1991 |
| Binding of rat chylomicrons and their remnants to the hepatic low-density-lipoprotein receptor and its role in remnant removal EET Windler, J Greeve, WH Daerr, H Greten Biochemical Journal 252 (2), 553-561, 1988 | 84 | 1988 |
| Characterization of the apolipoprotein B mRNA editing enzyme: no similarity to the proposed mechanism of RNA editing in kinetoplastid protozoa J Greeve, N Navaratnam, J Scott Nucleic acids research 19 (13), 3569-3576, 1991 | 80 | 1991 |
| The human asialoglycoprotein receptor is a possible binding site for low-density lipoproteins and chylomicron remnants E Windler, J Greeve, B Levkau, V Kolb-Bachofen, W Daerr, H Greten Biochemical Journal 276 (1), 79-87, 1991 | 74 | 1991 |
| Site-specific creation of uridine from cytidine in apolipoprotein B mRNA editing PE Hodges, N Navaratnam, JC Greeve, J Scott Nucleic acids research 19 (6), 1197-1201, 1991 | 69 | 1991 |
| Inhibition of the apolipoprotein B mRNA editing enzyme-complex by hnRNP C1 protein and 40S hnRNP complexes J Greeve, H Lellek, P Rautenberg, H Greten Walter de Gruyter, Berlin/New York 379 (8-9), 1063-1074, 1998 | 51 | 1998 |
| Effects of point mutations in the cytidine deaminase domains of APOBEC3B on replication and hypermutation of hepatitis B virus in vitro M Bonvin, J Greeve Journal of general virology 88 (12), 3270-3274, 2007 | 49 | 2007 |
| Hepatic gene transfer of the catalytic subunit of the apolipoprotein B mRNA editing enzyme results in a reduction of plasma LDL levels in normal and Watanabe heritable … J Greeve, VK Jona, NR Chowdhury, MS Horwitz, JR Chowdhury Journal of lipid research 37 (9), 2001-2017, 1996 | 49 | 1996 |
| Regulation of the hepatic removal of chylomicron remnants and beta-very low density lipoproteins in the rat. S Jäckle, F Rinninger, J Greeve, H Greten, E Windler Journal of lipid research 33 (3), 419-429, 1992 | 49 | 1992 |
| An additional editing site is present in apolipoprotein B mRNA N Navaratnam, D Patel, R Shah, JC Greeve, LM Powell, TJ Knott, J Scott Nucleic acids research 19 (8), 1741-1744, 1991 | 45 | 1991 |
| mFOLFOXIRI+ panitumumab versus FOLFOXIRI as first-line treatment in patients with RAS wild-type metastatic colorectal cancer m (CRC): a randomized phase II VOLFI trial of the … M Geissler, UM Martens, R Knorrenschield, J Greeve, A Florschuetz, ... Annals of Oncology 28, v159, 2017 | 40 | 2017 |
| Differences in the mechanisms of uptake and endocytosis of small and large chylomicron remnants by rat liver E Windler, J Greeve, H Robenek, F Rinninger, H Greten, S Jäckle Hepatology 24 (2), 344-351, 1996 | 40 | 1996 |
| Hepatic lipid accumulation, altered very low density lipoprotein formation and apolipoprotein E deposition in apolipoprotein E3-Leiden transgenic mice AR Mensenkamp, MJA van Luyn, H van Goor, V Bloks, F Apostel, ... Journal of hepatology 33 (2), 189-198, 2000 | 38 | 2000 |
